Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 218,091 | 340,275 | 262,623 | 169,268 | 319,125 |
| Marketable Securities | 185,192 | 206,337 | 269,025 | 261,348 | 266,548 |
| Receivables | 70,142 | 78,918 | 104,046 | 111,732 | 13,053 |
| Inventories | 61,783 | 71,836 | 72,125 | 70,870 | 472 |
| Other current assets | 2,484 | 21,879 | 26,859 | 81,700 | 0 |
| TOTAL | $540,619 | $721,182 | $737,556 | $698,224 | $599,518 |
| Non-Current Assets | |||||
| PPE Net | 26,630 | 27,769 | 29,120 | 29,048 | 1,679 |
| Investments And Advances | 162,185 | 175,787 | 197,690 | 259,717 | 359,229 |
| Intangibles | 234,411 | 245,393 | 248,780 | 261,634 | 18,948 |
| Other Non-Current Assets | 50,118 | 54,617 | 53,989 | 56,680 | 42,887 |
| TOTAL | $473,344 | $503,566 | $529,579 | $607,079 | $422,743 |
| Total Assets | $1,013,963 | $1,224,748 | $1,267,135 | $1,305,303 | $1,022,261 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 41,567 | 44,074 | 54,207 | 50,557 | N/A |
| Accounts payable and accrued liabilities | 42,475 | 66,518 | 79,770 | 72,831 | 9,298 |
| Accrued Expenses | N/A | N/A | N/A | 18,293 | N/A |
| Other current liabilities | 1,270 | 182,945 | 203,379 | 185,773 | 35,987 |
| TOTAL | $99,031 | $311,996 | $356,470 | $350,804 | $58,270 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,840 | 1,940 | 4,246 | 5,022 | N/A |
| Other Non-Current Liabilities | 8,878 | -79,467 | -90,575 | -102,676 | 5,109 |
| TOTAL | $32,710 | $33,754 | $34,304 | $39,393 | $5,812 |
| Total Liabilities | $131,741 | $345,750 | $390,774 | $390,197 | $64,082 |
| Shareholders' Equity | |||||
| Common Shares | 695,066 | 699,067 | 698,249 | 723,832 | 698,115 |
| Retained earnings | 166,306 | 58,209 | 40,760 | 52,246 | 227,405 |
| Other shareholders' equity | 2,647 | 17,708 | 27,619 | 18,190 | 16,694 |
| TOTAL | $882,222 | $791,866 | $783,561 | $810,731 | $958,179 |
| Total Liabilities And Equity | $1,013,963 | $1,137,616 | $1,174,335 | $1,200,928 | $1,022,261 |